The United States will cooperate with the United Kingdom to speed up the development of new antibiotics

Source: nai500 2016-07-29 the United States and the United Kingdom reached a new project to accelerate the development of new antibiotics, with a budget of hundreds of millions of dollars, aimed at solving the increasingly serious drug resistance problem The new partnership, called the anti antibiotic bacterial biomedical accelerator (carb-x), brings together government, academic and pharmaceutical industries to accelerate the development of new drugs and diagnostic methods The U.S Department of health and human services said Thursday it will provide $30 million in the first year and a total of $250 million over five years The UK centre for antimicrobial resistance will invest $14 million initially and $100 million over a five-year period In addition, the Wellcome Trust in London will also provide a fund of undisclosed amount The birth of carb-x originated from the cause of antibiotic resistant bacteria proposed by US President Barack Obama in 2015, as well as the investigation of antibiotic resistance launched by former Goldman Sachs economist Jim O'Neill for the British government in the world Jim O'Neill's final report, released in May this year, concluded that countries around the world need to work together to add new antibiotics and reduce the unnecessary use of existing antibiotics "Drug resistant bacterial infections have killed people all over the world," said Jeremy Farrar, head of Wellcome Trust "To solve this level of problem, we can only work together globally to curb the massive abuse of existing antibiotics and accelerate the development of new antibiotics." Carb-x will be headquartered at Boston University School of law, led by renowned health law researcher Kevin outerson.